The Remarkable Journey of Fondaparinux – Abdul Mannan
Dr. Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, shared on LinkedIn:
“The Remarkable Journey of Fondaparinux:
The story begins with Jay McLean’s accidental discovery of heparin at Johns Hopkins in 1916. Decades later, Harvard and Uppsala scientists revealed heparin’s mechanism – supercharging antithrombin by 1000-fold.
The Breakthrough (1980s):
Researchers discovered a pentasaccharide sequence within heparin was responsible for anticoagulation – The exact key that unlocks antithrombin’s potential.The Innovation (1987):
Maurice Petitou’s team at Institut Choay achieved the impossible – synthesizing the first artificial pentasaccharide (SR90107A/Org31540): The fondaparinux.Clinical Success (2002):
Trials involving 7,000+ patients, fondaparinux (Arixtra) showed 55% RR reduction in VTE. Sanofi brought this revolutionary anticoagulant to market.Why It Matters:
– Selective Xa inhibition
– No HIT risk
– Fixed dosing , no monitoring
– Synthetic precision over natural variabilityThis journey shows how molecular insight transforms patient care. Fondaparinux remains key in VTE prevention and led to modern anticoagulants.
What breakthrough in hemostasis research inspires you most?”
Don’t miss the latest updates with Hemostasis Today.
-
Nov 30, 2025, 13:23Ditte Vestergaard Hansen and Colleagues on Predictors of VTE Post-Stroke
-
Nov 30, 2025, 13:10Divyaswathi Citla Sridhar and Team Report Higher VTE Rates in Obese Users of Certain Estrogen-Progestin Combinations
-
Nov 30, 2025, 12:40Timos Papagatsias: Interested in Social Media in the Hematology Space?
-
Nov 30, 2025, 12:15Raphaël Liévin: In March 2026 SFH Will Host Its Very First Young EHA Research Meeting (YERM)!
-
Nov 30, 2025, 11:51Mohamed Aly Saad Aly on Microcatheters for Superselective Arterial Embolization
-
Nov 29, 2025, 18:55Ahmad Thuaimer: Success Story – Advanced Interventional Care for DVT
-
Nov 29, 2025, 17:37Almahdi Ali Explores Ipsilateral Paradoxical Thromboembolism at 22nd European Angiology Days 2025
-
Nov 29, 2025, 17:23Jack Shuang Hou Shares Major Neurology Updates This Week
-
Nov 29, 2025, 16:52Federica Fogacci on Further Strengthening Collaboration Within the Lp(a)CCELERATE Study

